GILEAD SCIENCES, INC. is 106.4x more valuable than Immunocore Holdings plc by market capitalization ($151.05 B vs $1.42 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMCR | GILD |
|---|---|---|
| Market cap | $1.42 B | $151.05 B |
| US-listed rank | #2369 | #99 |
| Revenue (latest FY) | $400.02M | $29.44B |
| Net income (latest FY) | -$35.51M | $8.51B |
| Net margin | -8.9% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 265 | 981 |
GILEAD SCIENCES, INC. is 106.4x more valuable than Immunocore Holdings plc by market capitalization ($151.05 B vs $1.42 B).
In their latest fiscal years, Immunocore Holdings plc reported $400.02M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: Immunocore Holdings plc and GILEAD SCIENCES, INC., or browse the full rankings.